These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

982 related articles for article (PubMed ID: 33163337)

  • 41. Activating Wnt/β-catenin signaling pathway for disease therapy: Challenges and opportunities.
    Huang P; Yan R; Zhang X; Wang L; Ke X; Qu Y
    Pharmacol Ther; 2019 Apr; 196():79-90. PubMed ID: 30468742
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dysregulation of Wnt/β-catenin signaling by protein kinases in hepatocellular carcinoma and its therapeutic application.
    Li Q; Sun M; Wang M; Feng M; Yang F; Li L; Zhao J; Chang C; Dong H; Xie T; Chen J
    Cancer Sci; 2021 May; 112(5):1695-1706. PubMed ID: 33605517
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeting the wingless signaling pathway with natural compounds as chemopreventive or chemotherapeutic agents.
    Teiten MH; Gaascht F; Dicato M; Diederich M
    Curr Pharm Biotechnol; 2012 Jan; 13(1):245-54. PubMed ID: 21466435
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potential Role of Traditional Chinese Medicines by Wnt/β-Catenin Pathway Compared With Targeted Small Molecules in Colorectal Cancer Therapy.
    Chang J; Xavier HW; Chen D; Liu Y; Li H; Bian Z
    Front Pharmacol; 2021; 12():690501. PubMed ID: 34381360
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of anticancer agents targeting the Wnt/β-catenin signaling.
    Zhang X; Hao J
    Am J Cancer Res; 2015; 5(8):2344-60. PubMed ID: 26396911
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Wnt/β-Catenin Signaling Pathway as Chemotherapeutic Target in Breast Cancer: An Update on Pros and Cons.
    Mukherjee N; Panda CK
    Clin Breast Cancer; 2020 Oct; 20(5):361-370. PubMed ID: 32416986
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Direct Targeting of β-Catenin by a Small Molecule Stimulates Proteasomal Degradation and Suppresses Oncogenic Wnt/β-Catenin Signaling.
    Hwang SY; Deng X; Byun S; Lee C; Lee SJ; Suh H; Zhang J; Kang Q; Zhang T; Westover KD; Mandinova A; Lee SW
    Cell Rep; 2016 Jun; 16(1):28-36. PubMed ID: 27320923
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nigericin Exerts Anticancer Effects on Human Colorectal Cancer Cells by Inhibiting Wnt/β-catenin Signaling Pathway.
    Liu F; Li W; Hua S; Han Y; Xu Z; Wan D; Wang Y; Chen W; Kuang Y; Shi J; Zhi Q
    Mol Cancer Ther; 2018 May; 17(5):952-965. PubMed ID: 29483216
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Advances in targeting the WNT/β-catenin signaling pathway in cancer.
    Chatterjee A; Paul S; Bisht B; Bhattacharya S; Sivasubramaniam S; Paul MK
    Drug Discov Today; 2022 Jan; 27(1):82-101. PubMed ID: 34252612
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of Wnt/β-catenin signaling attenuates axonal degeneration in models of Parkinson's disease.
    Huang YL; Zhang JN; Hou TZ; Gu L; Yang HM; Zhang H
    Neurochem Int; 2022 Oct; 159():105389. PubMed ID: 35809720
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance.
    Nagaraj AB; Joseph P; Kovalenko O; Singh S; Armstrong A; Redline R; Resnick K; Zanotti K; Waggoner S; DiFeo A
    Oncotarget; 2015 Sep; 6(27):23720-34. PubMed ID: 26125441
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Wnt/β-catenin pathway in bone cancers.
    Tian J; He H; Lei G
    Tumour Biol; 2014 Oct; 35(10):9439-45. PubMed ID: 25117074
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Wnt/β-catenin signaling in colorectal cancer: Is therapeutic targeting even possible?
    Disoma C; Zhou Y; Li S; Peng J; Xia Z
    Biochimie; 2022 Apr; 195():39-53. PubMed ID: 35066101
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Isoquercitrin suppresses colon cancer cell growth in vitro by targeting the Wnt/β-catenin signaling pathway.
    Amado NG; Predes D; Fonseca BF; Cerqueira DM; Reis AH; Dudenhoeffer AC; Borges HL; Mendes FA; Abreu JG
    J Biol Chem; 2014 Dec; 289(51):35456-67. PubMed ID: 25359775
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Curcumin Inhibits Gastric Carcinoma Cell Growth and Induces Apoptosis by Suppressing the Wnt/β-Catenin Signaling Pathway.
    Zheng R; Deng Q; Liu Y; Zhao P
    Med Sci Monit; 2017 Jan; 23():163-171. PubMed ID: 28077837
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Curcumin reversed chronic tobacco smoke exposure induced urocystic EMT and acquisition of cancer stem cells properties via Wnt/β-catenin.
    Liang Z; Lu L; Mao J; Li X; Qian H; Xu W
    Cell Death Dis; 2017 Oct; 8(10):e3066. PubMed ID: 28981096
    [TBL] [Abstract][Full Text] [Related]  

  • 57. β-catenin signaling: a novel mediator of fibrosis and potential therapeutic target.
    Lam AP; Gottardi CJ
    Curr Opin Rheumatol; 2011 Nov; 23(6):562-7. PubMed ID: 21885974
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Targeting Wnt/β-catenin signaling pathway in triple-negative breast cancer by benzylic organotrisulfides: Contribution of the released hydrogen sulfide towards potent anti-cancer activity.
    Bhattacherjee D; Raina K; Mandal TK; Thummer RP; Bhabak KP
    Free Radic Biol Med; 2022 Oct; 191():82-96. PubMed ID: 36038037
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A high-throughput screen for Wnt/β-catenin signaling pathway modulators in human iPSC-derived neural progenitors.
    Zhao WN; Cheng C; Theriault KM; Sheridan SD; Tsai LH; Haggarty SJ
    J Biomol Screen; 2012 Oct; 17(9):1252-63. PubMed ID: 22923789
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Potent growth suppressive activity of curcumin in human breast cancer cells: Modulation of Wnt/beta-catenin signaling.
    Prasad CP; Rath G; Mathur S; Bhatnagar D; Ralhan R
    Chem Biol Interact; 2009 Oct; 181(2):263-71. PubMed ID: 19573523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.